Tianhu Technology
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An AI-driven drug discovery platform company based in China.
OncologyImmunologyCentral Nervous System
Technology Platform
Develops AI and deep learning platforms for end-to-end drug discovery, including target identification, molecular design, and property prediction.
Opportunities
Benefits from strong government support and a vast domestic pharmaceutical market in China eager to adopt innovative R&D technologies.
Risk Factors
Must validate its platform by advancing multiple AI-generated drug candidates into and through clinical trials, a high bar that many AI biotechs have yet to clear.
Competitive Landscape
Operates in the highly competitive global AI drug discovery sector, vying for talent, data, and partnerships against well-funded US and European rivals.